ICLR · Icon PLC · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-09-17 | McCague Eugene Pacelli |
Director |
Convert↑
|
Ordinary Shares
|
3,255 |
| 2026-09-17 | Murphy Ronan Martin |
Director |
Sell↓
|
Ordinary Shares
|
5,005 |
| 2026-09-17 | Murphy Ronan Martin |
Director |
Convert↑
|
Ordinary Shares
|
5,005 |
| 2026-09-17 | McCague Eugene Pacelli |
Director |
Convert↓
Filing footnotes — Stock Options (Direct)
Fully vested. The stock options expire on the eighth anniversary of the grant date, May 18, 2018, subject to automatic extension until the 30th trading day following any period during which exercise is prohibited under the Issuer's Share Trading Policy or applicable law, but in no event later than the tenth anniversary of the grant date. |
Stock Options
|
3,255 |
| 2026-09-17 | Murphy Ronan Martin |
Director |
Convert↓
Filing footnotes — Stock Options (Direct)
Fully vested. The stock options expire on the eighth anniversary of the grant date, May 18, 2018, subject to automatic extension until the 30th trading day following any period during which exercise is prohibited under the Issuer's Share Trading Policy or applicable law, but in no event later than the tenth anniversary of the grant date. |
Stock Options
|
5,005 |
| 2026-09-17 | McCague Eugene Pacelli |
Director |
Sell↓
|
Ordinary Shares
|
3,255 |
| 2026-09-16 | CLIMAX JOHN DR |
Director |
Convert↑
|
Ordinary Shares
|
5,005 |
| 2026-09-16 | CLIMAX JOHN DR |
Director |
Convert↓
Filing footnotes — Stock Options (Direct)
Fully vested. The stock options expire on the eighth anniversary of the grant date, May 18, 2018, subject to automatic extension until the 30th trading day following any period during which exercise is prohibited under the Issuer's Share Trading Policy or applicable law, but in no event later than the tenth anniversary of the grant date. |
Stock Options
|
5,005 |
| 2026-09-16 | CLIMAX JOHN DR |
Director |
Sell↓
|
Ordinary Shares
|
5,005 |
| 2026-08-11 | Whitaker Anne Clem |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $163.15 to $164.1499, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
96 |
| 2026-08-11 | McCague Eugene Pacelli |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $163.15 to $164.1499, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
96 |
| 2026-08-11 | Clerkin Nigel Bernard John |
Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $163.15 to $164.1499, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
259 |
| 2026-08-11 | Murphy Ronan Martin |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $164.16 to $165.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
590 |
| 2026-08-11 | Whitaker Anne Clem |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $162.08 to $163.0799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
88 |
| 2026-08-11 | Murray Ciaran |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The Reporting Person sold all shares that vested on August 10, 2026, including shares to cover tax withholding obligations in connection with the vesting of compensatory equity awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $163.15 to $164.1499, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
305 |
| 2026-08-11 | Clerkin Nigel Bernard John |
Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $162.08 to $163.0799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
237 |
| 2026-08-11 | Grais Linda |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $164.16 to $165.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
590 |
| 2026-08-11 | O'Neill Julie |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $163.15 to $164.1499, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
105 |
| 2026-08-11 | CLIMAX JOHN DR |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $165.16 to $166.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
67 |
| 2026-08-11 | Murphy Ronan Martin |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $165.16 to $166.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
67 |
| 2026-08-11 | Clerkin Nigel Bernard John |
Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $164.16 to $165.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
1,591 |
| 2026-08-11 | Grais Linda |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $163.15 to $164.1499, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
97 |
| 2026-08-11 | Clerkin Nigel Bernard John |
Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $165.16 to $166.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
180 |
| 2026-08-11 | O'Neill Julie |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $164.16 to $165.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
642 |
| 2026-08-11 | Murray Ciaran |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The Reporting Person sold all shares that vested on August 10, 2026, including shares to cover tax withholding obligations in connection with the vesting of compensatory equity awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $164.16 to $165.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
1,880 |
| 2026-08-11 | Murphy Ronan Martin |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $163.15 to $164.1499, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
96 |
| 2026-08-11 | Whitaker Anne Clem |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $164.16 to $165.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
590 |
| 2026-08-11 | Murray Ciaran |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The Reporting Person sold all shares that vested on August 10, 2026, including shares to cover tax withholding obligations in connection with the vesting of compensatory equity awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $162.08 to $163.0799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
280 |
| 2026-08-11 | CLIMAX JOHN DR |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $163.15 to $164.1499, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
95 |
| 2026-08-11 | Grais Linda |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $162.08 to $163.0799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
87 |
| 2026-08-11 | O'Neill Julie |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $162.08 to $163.0799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
95 |
| 2026-08-11 | McCague Eugene Pacelli |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $165.16 to $166.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
67 |
| 2026-08-11 | McCague Eugene Pacelli |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $164.16 to $165.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
590 |
| 2026-08-11 | O'Neill Julie |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $165.16 to $166.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
73 |
| 2026-08-11 | CLIMAX JOHN DR |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $164.16 to $165.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
591 |
| 2026-08-11 | Murray Ciaran |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The Reporting Person sold all shares that vested on August 10, 2026, including shares to cover tax withholding obligations in connection with the vesting of compensatory equity awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $165.16 to $166.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
212 |
| 2026-08-11 | CLIMAX JOHN DR |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $162.08 to $163.0799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
88 |
| 2026-08-11 | Murphy Ronan Martin |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $162.08 to $163.0799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
88 |
| 2026-08-11 | Whitaker Anne Clem |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $165.16 to $166.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
67 |
| 2026-08-11 | McCague Eugene Pacelli |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $162.08 to $163.0799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
88 |
| 2026-08-11 | Grais Linda |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $165.16 to $166.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. |
Ordinary Shares
|
67 |
| 2026-08-10 | CLIMAX JOHN DR |
Director |
Award↑
Filing footnotes — Restricted Share Units (Direct)
Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting. These restricted share units were granted on August 10, 2026 and are scheduled to vest on May 22, 2027. |
Restricted Share Units
|
1,324 |
| 2026-08-10 | Elliott Jeffrey Thomas |
Director |
Award↑
Filing footnotes — Restricted Share Units (Direct)
Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting. These restricted share units were granted on August 10, 2026 and are scheduled to vest on May 22, 2027. |
Restricted Share Units
|
1,324 |
| 2026-08-10 | McCague Eugene Pacelli |
Director |
Award↑
Filing footnotes — Restricted Share Units (Direct)
Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting. These restricted share units were granted on August 10, 2026 and are scheduled to vest on May 22, 2027. |
Restricted Share Units
|
1,324 |
| 2026-08-10 | Murray Ciaran |
Director |
Award↑
Filing footnotes — Restricted Share Units (Direct)
Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting. These restricted share units were granted on August 10, 2026 and are scheduled to vest on May 22, 2027. |
Restricted Share Units
|
2,047 |
| 2026-08-10 | Whitaker Anne Clem |
Director |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
These restricted share units were granted on May 22, 2025 and vested on August 10, 2026. Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting. |
Ordinary Shares
|
1,732 |
| 2026-08-10 | CLIMAX JOHN DR |
Director |
Convert↓
Filing footnotes — Restricted Share Units (Direct)
Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting. These restricted share units were granted on May 22, 2025 and vested on August 10, 2026. |
Restricted Share Units
|
1,732 |
| 2026-08-10 | Murphy Ronan Martin |
Director |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
These restricted share units were granted on May 22, 2025 and vested on August 10, 2026. Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting. |
Ordinary Shares
|
1,732 |
| 2026-08-10 | Balfe Barry Edward |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Options (Direct)
These stock options were granted on August 10, 2026 and are scheduled to vest in four approximately equal installments on March 8, 2027, March 8, 2028, March 8, 2029, and March 8, 2030. The stock options expire on the eighth anniversary of the grant date, subject to automatic extension until the 30th trading day following any period during which trading is prohibited under the Issuer's Share Trading Policy or applicable law, but in no event later than the tenth anniversary of the grant date. |
Stock Options
|
32,635 |
| 2026-08-10 | Whitaker Anne Clem |
Director |
Convert↓
Filing footnotes — Restricted Share Units (Direct)
Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting. These restricted share units were granted on May 22, 2025 and vested on August 10, 2026. |
Restricted Share Units
|
1,732 |